UNSPSC 51373423: Chlorpheniramine/codeine/phenylephrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373423 Chlorpheniramine/codeine/phenylephrine is a Commodity code nominally identifying a specific pharmaceutical formulation, but recent state and local opportunities tagged under this code show substantial mismatch with its nominal scope. The two recent opportunities on record involve naloxone and safe drug deactivation systems (Seminole County, Florida), and generic multi-source pharmaceuticals and OTC products across a multistate cooperative purchasing vehicle (Minnesota Multistate Cooperative Purchasing Alliance). Neither procurement is actually seeking chlorpheniramine/codeine/phenylephrine products. The code shows little relevant recent activity aligned with its stated pharmaceutical formulation.

Issuing bodies include a county government (Seminole County) and a state cooperative purchasing program (MMCAP, administered by the Minnesota Department of Administration). Geographically, the recent activity spans Florida and Minnesota-led multistate participation including Oregon. The Seminole County opportunity (IFB 60459723LAS, due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually on a two-year initial term with one-year renewal option; MMCAP's RFP (S1070000015802, due March 26, 2026) established multiple contracts for generic pharmaceuticals and OTC products through three authorized wholesalers, with contract effectiveness July 1, 2026, and a two-year initial term. The code assignment appears to be a data-entry or taxonomy-mapping error rather than a reflection of the actual pharmaceutical commodities being procured under current state and local solicitations.